Inactive Instrument

News DelMar Pharmaceuticals Inc Nasdaq

Equities

US2470782077

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA	Apr. 09	PR
KINTARA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Kintara Therapeutics, Inc. - KTRA	Apr. 05	BU
Sector Update: Health Care Stocks Softer Late Afternoon	Apr. 03	MT
Sector Update: Health Care	Apr. 03	MT
Top Midday Gainers	Apr. 03	MT
Shareholder Alert: Ademi LLP investigates whether Kintara Therapeutics, Inc. has obtained a Fair Price in its transaction with TuHURA	Apr. 03	PR
KTRA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Kintara Therapeutics, Inc. Is Fair to Shareholders	Apr. 03	BU
Transcript : Kintara Therapeutics, Inc., TuHURA Biosciences, Inc. - M&A Call	Apr. 03
TuHURA Biosciences, Inc. entered into a definitive agreement to acquire Kintara Therapeutics, Inc. in a reverse merger transaction.	Apr. 02	CI
TuHURA Biosciences, Inc. agreed to acquire Kintara Therapeutics, Inc. in a reverse merger transaction.	Apr. 02	CI
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	Mar. 27	PR
Kintara Therapeutics Announces Expansion of REM-001 Clinical Study to Include Patients on Pembrolizumab	Mar. 27	CI
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	Feb. 21	AQ
Kintara Therapeutics Continues to Evaluate Strategic Options	Feb. 15	CI
Kintara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 14	CI
Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update	Feb. 14	PR
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	Feb. 12	PR
Kintara Therapeutics, Inc. Announces Initiation of Rem-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer	Feb. 12	CI
Wall Street Set for Cautious Opening in Final Trading Day of a Bullish 2023	Dec. 29	MT
Index Futures Edge Higher to End Mostly Positive Year on High Note	Dec. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News DelMar Pharmaceuticals Inc Nasdaq

Equities

US2470782077

Summary

Filters